Parfet Donald R

Director at MAS; Director at KELYA; Director at ROK

Sold, on record
$2.5M
Dollars the filings state
Form 4 sales
6
Latest Nov 2, 2020
Form 144 notices
0
Proposed sales
Quarters with a sale
0 of the last 8
No sale in two years
Companies
3
Filed as an executive or holder

Companies

  • MASMASCO CORP /DE/Director
  • KELYAKELLY SERVICES INCDirector
  • ROKROCKWELL AUTOMATION, INCDirector

Sales by reason

0
Routine
3
Plan not stated
0
No plan
3
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Nov 2, 2020Plan not stated

    MAS

    Sold 10.7% of their holdings

    $206k3,783 shares at $54.44

    Filed Nov 3, 2020Form 4

  2. Feb 13, 2020Plan not stated

    MAS

    Sold 19.4% of their holdings

    $355k7,622 shares at $46.52

    Filed Feb 14, 2020Form 4

  3. Jun 9, 2017Unusual

    KELYA

    Sold 48.4% of their holdings

    $509k22,029 shares at $23.10

    Filed Jun 12, 2017Form 4

  4. May 19, 2016Unusual

    ROK

    Sold 34.6% of their holdings

    $519k4,674 shares at $111.08

    Filed May 20, 2016Form 4

  5. Aug 13, 2013Plan not stated

    ROK

    Sold 8.9% of their holdings

    $98k992 shares at $99.28

    Filed Aug 14, 2013Form 4

  6. Aug 7, 2013Unusual

    ROK

    Sold 42.1% of their holdings

    $802k8,125 shares at $98.73

    Filed Aug 8, 2013Form 4

6 of 6

Every transaction

Every transaction on a Form 4 or Form 5 by Parfet Donald R
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Feb 10, 2026Feb 11, 2026ROKDirectorExercised or settledRestricted Stock Units2,1620SEC
Feb 10, 2026Feb 11, 2026ROKDirectorExercised options2,16214,497SEC
Dec 8, 2025Dec 10, 2025ROKDirectorAwarded49812,335SEC
Aug 28, 2025Sep 2, 2025ROKDirectorGift1,07011,837SEC
Dec 5, 2024Dec 6, 2024ROKDirectorAwarded67412,907SEC
Aug 1, 2024Aug 5, 2024MASDirectorGift1,86832,370SEC
Jul 30, 2024Aug 1, 2024MASDirectorGift2,80234,238SEC
May 10, 2024May 14, 2024MASDirectorAwarded2,4908,344SEC
May 9, 2024May 10, 2024KELYADirectorAwarded6,811$22.02$150k100,296SEC
Dec 4, 2023Dec 5, 2023ROKDirectorAwarded71612,233SEC
Aug 29, 2023Aug 30, 2023ROKDirectorGift1,10011,517SEC
Aug 22, 2023Aug 24, 2023MASDirectorGift3,0065,854SEC
May 17, 2023May 18, 2023KELYADirectorAwarded6,815$18.34$125k93,485SEC
May 11, 2023May 12, 2023MASDirectorAwarded3,0408,860SEC
Dec 9, 2022Dec 12, 2022ROKDirectorAwarded77012,617SEC
Aug 15, 2022Aug 16, 2022KELYADirectorBought11,000$18.34$202k86,670SEC
Aug 2, 2022Aug 3, 2022MASDirectorGift3,2605,820SEC
May 18, 2022May 19, 2022KELYADirectorAwarded8,625$19.13$165k75,670SEC
May 12, 2022May 16, 2022MASDirectorAwarded2,9309,080SEC
Feb 10, 2022Feb 16, 2022MASDirectorGift27,9246,150SEC
Dec 16, 2021Dec 16, 2021KELYADirectorBought14,000$17.71$248k67,045SEC
Dec 7, 2021Dec 8, 2021ROKDirectorAwarded42111,847SEC
May 18, 2021May 19, 2021KELYADirectorAwarded6,490$25.42$165k53,045SEC
May 12, 2021May 14, 2021MASDirectorAwarded2,58034,074SEC
Feb 2, 2021Feb 3, 2021ROKDirectorAwarded15911,426SEC
Nov 2, 2020Nov 3, 2020MASDirectorSold3,783$54.44$206k31,494SEC
Oct 1, 2020Oct 2, 2020ROKDirectorAwarded49011,267SEC
May 26, 2020May 28, 2020ROKDirectorGift1,74410,431SEC
May 13, 2020May 15, 2020MASDirectorAwarded3,51035,277SEC
May 6, 2020May 7, 2020KELYADirectorAwarded12,880$12.81$165k46,555SEC
Feb 13, 2020Feb 14, 2020MASDirectorSold7,622$46.52$355k31,767SEC
Feb 4, 2020Feb 6, 2020ROKDirectorAwarded19812,175SEC
Oct 1, 2019Oct 2, 2019ROKDirectorAwarded66311,977SEC
Jun 11, 2019Jun 12, 2019ProNAi Therapeutics IncDirectorAwardedStock Option (right to buy)30,00030,000SEC
May 10, 2019May 14, 2019MASDirectorAwarded3,69039,389SEC
May 8, 2019May 9, 2019KELYADirectorAwarded6,578$25.08$165k33,675SEC
Feb 5, 2019Feb 6, 2019ROKDirectorAwarded23511,314SEC
Oct 1, 2018Oct 2, 2018ROKDirectorAwarded50611,079SEC
Jun 14, 2018Jul 3, 2018MASDirectorGift8080SEC
Jun 12, 2018Jun 14, 2018ProNAi Therapeutics IncDirectorAwardedStock Option (right to buy)25,00025,000SEC
Jun 11, 2018Jun 28, 2018ROKDirectorInherited1717SEC
May 11, 2018May 15, 2018MASDirectorAwarded3,68035,699SEC
May 9, 2018May 10, 2018KELYADirectorAwarded3,577$30.75$110k27,097SEC
Feb 6, 2018Feb 7, 2018ROKDirectorAwarded21310,573SEC
Jan 4, 2018Jan 8, 2018ProNAi Therapeutics IncDirectorOther10,28377,235SEC
Oct 2, 2017Oct 3, 2017ROKDirectorAwarded51210,360SEC
Jun 13, 2017Jun 14, 2017ProNAi Therapeutics IncDirectorAwardedStock Option (right to buy)25,00025,000SEC
Jun 9, 2017Jun 12, 2017KELYADirectorSold22,029$23.10$509k23,520SEC
May 12, 2017May 16, 2017MASDirectorAwarded3,57032,019SEC
May 11, 2017May 15, 2017KELYADirectorAwarded3,493$22.90$80k45,549SEC
Page 1

Sales and notices (6)

Form 144 notices and Form 4 sales by Parfet Donald R
Source
Nov 2, 2020Nov 3, 2020MASDirectorForm 4 sale3,783$206k10.7%Plan not statedSEC
Feb 13, 2020Feb 14, 2020MASDirectorForm 4 sale7,622$355k19.4%Plan not statedSEC
Jun 9, 2017Jun 12, 2017KELYADirectorForm 4 sale22,029$509k48.4%UnusualSEC
May 19, 2016May 20, 2016ROKDirectorForm 4 sale4,674$519k34.6%UnusualSEC
Aug 13, 2013Aug 14, 2013ROKDirectorForm 4 sale992$98k8.9%Plan not statedSEC
Aug 7, 2013Aug 8, 2013ROKDirectorForm 4 sale8,125$802k42.1%UnusualSEC